Kazia Therapeutics Limited (KZIA)
NASDAQ·Healthcare·Biotechnology
$11.98
+0.21%
Mkt Cap $13.31M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | — | $253.00K | — | -$0.01 | -$0.41 | -5760.55% | — | — |
| Q2 2025 Jun 30, 2025 | $10.45K | $12.87K | +23.17% | -$0.01 | -$4.18 | -63968.61% | — | — |
| Q2 2025 May 28, 2025 | — | $13.80K | — | -$10.76 | -$7.61 | +29.29% | — | — |
| Q4 2024 Nov 19, 2024 | $100.00K | $1.65M | +1554.23% | -$15.00 | -$20.81 | -38.75% | — | — |
| Q1 2024 Mar 27, 2024 | — | $3 | — | — | -$12.53 | — | — | — |
| Q4 2023 Nov 27, 2023 | — | $664 | — | -$1.66 | -$10.02 | -504.79% | — | — |
| Q1 2023 Mar 9, 2023 | $7.75K | — | — | -$24.65 | -$31.86 | -29.27% | — | — |
| Q4 2022 Oct 6, 2022 | — | — | — | — | -$30.53 | — | — | — |
| Q1 2022 Jan 6, 2022 | — | $7.25K | — | — | -$36.25 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | $11.40M | — | — | -$5.85 | — | — | — |
| Q4 2020 Dec 31, 2020 | $456.57K | $897 | -99.80% | -$2.30 | -$22.72 | -885.78% | — | — |
| Q2 2020 Jun 30, 2020 | $2.37M | $251.13K | -89.39% | — | -$26.84 | — | — | — |
| Q4 2019 Dec 31, 2019 | — | $440.05K | — | — | -$30.27 | — | — | — |
| Q2 2019 Jun 30, 2019 | — | $469.59K | — | — | -$22.86 | — | — | — |
| Q4 2018 Dec 31, 2018 | — | $594.07K | — | — | -$42.21 | — | — | — |
| Q2 2018 Jun 30, 2018 | — | $1.14M | — | — | -$47.10 | — | — | — |
| Q4 2017 Dec 31, 2017 | — | $1.12M | — | — | $3.24 | — | — | — |
| Q3 2017 Aug 30, 2017 | — | $3.22M | — | — | -$49.24 | — | — | — |
| Q1 2017 Feb 22, 2017 | — | $3.30M | — | — | -$31.88 | — | — | — |
| Q3 2016 Aug 30, 2016 | — | $176.14K | — | — | -$68.46 | — | — | — |